Shares of ZIVO Bioscience, Inc. (NASDAQ:ZIVO – Get Free Report) crossed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $3.83 and traded as high as $4.15. ZIVO Bioscience shares last traded at $3.7150, with a volume of 2,032 shares traded.
ZIVO Bioscience Price Performance
The firm’s fifty day moving average is $3.83 and its 200 day moving average is $7.44. The firm has a market capitalization of $15.42 million, a price-to-earnings ratio of -0.76 and a beta of 0.04.
About ZIVO Bioscience
ZIVO Bioscience is a clinical-stage biotechnology company focused on developing precision live biotherapeutics to prevent and treat gastrointestinal infections in both animal and human health markets. The company applies synthetic biology, microbiology and fermentation technologies to engineer proprietary bacterial strains that produce targeted lactic acid and antimicrobial compounds. Its pipeline includes ZB-01, an orally administered therapy for recurrent Clostridioides difficile infections in humans, and ZB-02, a feed-additive candidate aimed at reducing Salmonella colonization in poultry.
Founded in 2016 and headquartered in Carlsbad, California, ZIVO Bioscience leverages exclusive licensing agreements with academic institutions to advance its lead programs through preclinical and early clinical development.
See Also
- Five stocks we like better than ZIVO Bioscience
- Coke’s $10B India IPO Plan Pops the Top on Hidden Value
- FedEx Unboxes Billions in Post-Spinoff Value
- Marvell’s AI Moment Raises a Bigger Question for Amazon and ServiceNow
- Palo Alto Networks Accelerates Growth 31% on AI Demand
Receive News & Ratings for ZIVO Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZIVO Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
